Yabao Pharmaceutical Group Co. Ltd. Class ASSE: 600351

Announcement on Obtaining Notice of Approval for Drug Clinical Trials of Scopolamine Transdermal Patch

· Issued by Yabao Pharmaceutical Group Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Obtaining Notice of Approval for Drug Clinical Trials of Scopolamine Transdermal Patch

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Earlier from Yabao Pharmaceutical Group Co. Ltd. Class A

All Yabao Pharmaceutical Group Co. Ltd. Class A news releases